Table 2.
Twenty year risks of incident liver complications, life expectancy, and quality adjusted life expectancy depending on antiviral treatment (rounded undiscounted values)
| No antiviral treatment | Interferon plus ribavirin | Peginterferon plus fixed ribavirin | Peginterferon plus weight based ribavirin | |
| 20 year risk (%) | ||||
| Compensated cirrhosis | 62 | 34 | 29 | 25 |
| Decompensated cirrhosis | 24 | 14 | 12 | 11 |
| Hepatocellular carcinoma | 9.7 | 5.8 | 5.3 | 4.7 |
| Liver transplantation* | 2.3 | 1.3 | 1.2 | 1.1 |
| Liver-related death | 24 | 14 | 13 | 11 |
| Life expectancy (years) | 25.8 | 29.4 | 30.0 | 30.5 |
| Quality adjusted life expectancy (QALY) | 22.8 | 26.6 | 27.1 | 27.7 |
*Only first transplantations included (no retransplantations).